In a similar PyMT tumor cell transplant paradigm to ours, the population of CD24 (heat stable antigen)hi/CD29(β1-integrin)+/CD61(β3-integrin)+ cells was found to significantly increase during tumor progression, specifically at the transition from hyperplasia to carcinoma. Here, CD24 is linked to carcinoma.